RecruitingNCT07281352
Psilocybin with 12-session CBT for depression
About this title
Read the official source — NCT07281352Medication studyAges 21–60United States
Understand this study
Who could participate?
Listed age limits: 21 years to 60 years.
- Listed locations
- Los AngelesSee all locations and recruitment
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: January 5, 2026
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 50
- Sponsor
- University of California, Los Angeles
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Behavioural, Drug
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- United States
- Age range
- From 21 Years to 60 Years
- Official registry ID
- NCT07281352
- Official title
Show the full official title
Psilocybin-Assisted Cognitive Behavioral Therapy for Depression
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Los Angeles
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of California, Los Angeles, a university.
Does this study involve medication?
Yes. The study involves medication, including Psilocybin (drug).
Who can participate?
Listed age limits: 21 years to 60 years.
Is this study still recruiting?
The registry lists this study as recruiting.
